First Posted: Jul 12, 2021 09:02 PM EDT Photo : Francisco Vega/Getty Images The U.S. Food and Drug Administration issued a new warning on Monday about an increased risk of autoimmune disorder Guillain-Barre linked to the Johnson & Johnson COVID vaccine. The released warning came after 100 preliminary cases of the rare-neurological disorder were reported among the 12.5 million doses administered, according to an ABC News Go report. The FDA also reported that the 95 cases were serious and required admission to the hospital, while there was also one death. The agency said that they have evaluated the available information for Johnson & Johnson COVID vaccine and continue to find the known and potential benefits clearly outweigh the possible risks.